ObsEva (NASDAQ:OBSV) Now Covered by StockNews.com

Posted by on Oct 31st, 2024

StockNews.com initiated coverage on shares of ObsEva (NASDAQ:OBSV – Free Report) in a report published on Wednesday. The firm issued a hold rating on the stock.

ObsEva Stock Performance

The firm has a market capitalization of $7.94 million, a PE ratio of -0.11 and a beta of 0.68. The stock’s fifty day simple moving average is $0.01. ObsEva has a 12 month low of $0.08 and a 12 month high of $2.14.

About ObsEva

(Get Free Report)

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.

Read More

Receive News & Ratings for ObsEva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ObsEva and related companies with MarketBeat.com's FREE daily email newsletter.